Who is the CEO of CG Oncology, Inc. Common stock?

The CEO of CG Oncology, Inc. Common stock is Arthur Kuan.

What industry does CG Oncology, Inc. Common stock belong to?

CG Oncology, Inc. Common stock operates in the Biotechnology industry within the Healthcare sector.

Where is CG Oncology, Inc. Common stock headquartered?

CG Oncology, Inc. Common stock is headquartered at 400 Spectrum Center Drive, Irvine, DE, US.

How many employees does CG Oncology, Inc. Common stock have?

CG Oncology, Inc. Common stock has approximately 113 full-time employees.

CG Oncology, Inc. Common stock

CGON•NASDAQ

Healthcare

Biotechnology

$26.31

$-0.38(-1.42%)

CG Oncology, Inc. Common stock (CGON) Company Profile & Overview

Explore CG Oncology, Inc. Common stock’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

CG Oncology, Inc. Common stock (CGON) Company Profile & Overview

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

SectorHealthcare

IndustryBiotechnology

CEOArthur Kuan

Contact Information

https://cgoncology.com

400 Spectrum Center Drive, Irvine, DE

Company Facts

113 Employees

CountryUS

Actively Trading

Frequently Asked Questions

;